Symptoms of VEXAS syndrome, first discovered in 2020, are highly variable and nonspecific.
To err on the side of caution, some ophthalmologists are now actively bringing up possible risks of the vaccines to their patients.
Concerns about side effects and under-researched adverse events have prompted nations around the world to call for the suspension of the COVID-19 vaccine.
Symptoms of VEXAS syndrome, first discovered in 2020, are highly variable and nonspecific.
To err on the side of caution, some ophthalmologists are now actively bringing up possible risks of the vaccines to their patients.
Concerns about side effects and under-researched adverse events have prompted nations around the world to call for the suspension of the COVID-19 vaccine.